The formation of the cell septum in the bacterium Escherichia coli takes place at a precise place in the cell and at a precise time in the division cycle. A number of genes have been identified that appear to play essential roles in this process, including a cluster of fts (temperature-sensitive filamentation) genes located in the min-2 region of the E. coli chromosome. The ftsZ gene encodes an abundant cytoplasmic protein which forms a ring near the site of cell division prior to the formation of the cell septum (2) . The ftsA gene encodes a peripheral membrane protein that may interact with FtsZ (9) . Three genes in this cluster, ftsI, ftsQ, and ftsL, code for cytoplasmic membrane proteins with simple structures (4, 7, 18) . Each of these three proteins has a similar topological organization: an amino-terminal hydrophilic cytoplasmic sequence, a single hydrophobic transmembrane segment, and a hydrophilic periplasmic domain (Fig. 1) . Proteins with this topology have been termed bitopic membrane proteins. All three proteins are made in very small amounts, with estimates ranging from 25 to 150 molecules per cell (1, 7, 11, 18) .
The ftsI gene codes for a penicillin-binding protein (PBP), PBP3, which exhibits a transpeptidase activity related to peptidoglycan synthesis (22) . (We refer to this protein as FtsI throughout this paper.) This activity is encoded in the portion of the polypeptide chain which is localized to the periplasm. Mutations and antibiotics that inactivate FtsI prevent septum formation but do not interfere with cell elongation (38) . The enzymatic activity of FtsI is thus presumed to have a role in peptidoglycan synthesis only during septum formation. FtsI is localized to the cell septum at later stages of cell growth (42) .
While mutations in the ftsL and ftsQ genes have phenotypes very similar to those in the ftsI gene, very little information about the functions of these two Fts membrane proteins exists. The periplasmic domain of FtsL is composed of an amino acid sequence which has features of an ␣-helical leucine zipper (18) . Preliminary mutagenesis data on this domain of FtsL are consistent with its functioning as a leucine zipper, although no direct evidence for this proposed role has been obtained (18a) . No information about the possible function of any of the domains of FtsQ exists.
We are interested in studying the role of this set of membrane proteins in the cell division process. As part of these studies, we are seeking to determine the functions of the domains of each of the proteins that are located in the three different subcellular compartments-the cytoplasm, the membrane, and the periplasm. Because of their simple bitopic structure, these proteins can be readily dissected into their component parts. Studies of many membrane proteins involved in other cellular processes have pointed to a variety of different possible roles for their membrane-spanning segments (MSSs). Among these roles are (i) membrane anchors for the cytoplasmic and/or exported domain of a protein (reference 27 and results for FtsQ described below), (ii) domains for homodimerization of the protein (24) , (iii) domains of interaction with MSS of other membrane proteins (3, 8) , (iv) functional domains in proteins that act as channels or pores in the membrane (20) , and (v) signals for subcellular localization, for instance to the Golgi compartments in eukaryotic cells (30, 32) .
The cytoplasmic domains of bitopic membrane proteins have also been studied. In eukaryotic cells, sequence motifs in these domains sometimes act to localize proteins to specific subcellular compartments such as the endoplasmic reticulum or the lysosome (17, 31, 37) . For bitopic membrane proteins that act as signalling molecules, the cytoplasmic domains can activate regulatory cascades or even directly regulate gene expression. In other cases, the sequences appear to act only as part of the anchoring portion of the protein, ensuring its proper topology and arrangement. In these cases, replacing the domain with another unrelated but suitable sequence may result in a protein that is still functional (35) .
In many cases, the exported portion of this class of membrane proteins encodes the primary functional activity. Examples are PBPs in E. coli (15) and a host of membrane receptors in eukaryotic cells.
To determine the roles of the various domains of the Fts membrane proteins, we have initiated an approach involving the exchange of domains between them. In addition, we have exchanged into these proteins a cytoplasmic and/or MSS domain of a protein involved in a process totally unrelated to cell division. For these latter constructs, we have chosen the membrane protein MalF, which is required for maltose transport in E. coli (14, 21) . The simplified rationale behind this approach is as follows. Replacing any one domain of a protein with that of another and assaying the protein's function would indicate whether the sequence of that specific domain is required for the function of the protein. If any of the domains are required for subcellular localization to the cell septum, then those domains may be exchangeable among the Fts proteins; however, the MalF domain would not suffice for proper function. If any pair or if all three of the proteins form a complex via, e.g., their MSSs, then certain classes of exchanges may complement each other, even though a single exchange may eliminate the function.
According to this simple rationale, such studies could reveal the important domains of a protein and thus allow a focus for further genetic and biochemical analyses. We recognize (see Discussion) that the results of such an analysis will likely be more difficult to evaluate than this simple description would suggest. However, we believe, as illustrated by the results described below, that these findings open new avenues of research that are important both for understanding how the Fts proteins function and for understanding some important features of the organization of membrane proteins in general.
MATERIALS AND METHODS
Strains, plasmids, and media. The strains and plasmids used in this study are listed in Table 1 . Rich and minimal media were NZY and M63, respectively (18, 19) . Ampicillin was used at 200 g/ml in rich medium and at 50 g/ml in minimal medium. Kanamycin was used at 60 or 100 g/ml in minimal medium and at 40 g/ml in rich medium. Minimal medium contained thiamine (0.5 g/ml) and 0.01% leucine and 0.005% isoleucine for complementation of temperaturesensitive (Ts) mutants, but not for transductions. L-Arabinose (0.2, 0.02, 0.002, and 0.0002%) or D-glucose (0.2%) was added to medium to modulate expression of fts alleles cloned under control of the P BAD promoter (pBAD derivatives [19] ). In addition, minimal medium always contained 0.2% glycerol, which served as the primary carbon source on plates containing low concentrations of arabinose or glucose.
Complementation. (i) Complementation of Ts mutants. Swap constructs and control plasmids were transformed into strains carrying Ts alleles of either ftsI or ftsQ, selecting for ampicillin resistance on NZY plates at 30°C. Isolates were tested for complementation by streaking onto NZY-ampicillin and M63-ampicillin plates with and without arabinose or glucose (to modulate expression of the FIG. 1. Membrane topology of proteins used in this study (see introduction for details). From MalF, only the short amino-terminal cytoplasmic domain and the first MSS were used. These can be deleted without affecting the transport activity of MalF. a.a., amino acid. (ii) Complementation of null mutants by transduction. Swap constructs were tested for complementation by transduction essentially as previously described (7, 19) . Briefly, derivatives of LMG194 (ftsL ϩ ftsI ϩ ftsQ ϩ leu::Tn10) carrying plasmids encoding the swap alleles to be tested (or control plasmids) were transduced to kanamycin resistance and leucine prototrophy on M63 plates. The lysates were prepared on LMG145 (ftsL::TnphoA Leu ϩ /pLMG180), MJC431 (ftsI::TnphoA Leu ϩ /pLMG173), or MJC295 (ftsQ::TnphoA Leu ϩ /pLMG161). The plates were incubated at 37°C and examined daily for at least 3 days, by which time complementing plasmids typically yielded 50 to 100 transductants per plate, while noncomplementing plasmids yielded fewer than 5 transductants per plate. Some of the transductants were made phage free and analyzed. Isolates obtained from complementing plasmids bred true and contained the plasmid originally present in the recipient, as expected, whereas isolates obtained from noncomplementing plasmids often gave rise to faster-growing variants upon restreaking and contained the fts ϩ plasmid from the donor strain. The degrees of complementation of ftsL and ftsI mutants by swap proteins with P1 transductions were tested on plates containing 0.2, 0.02, and 0.002% arabinose, no sugar, and 0.2% glucose. For ftsQ, 0.2 and 0.002% arabinose and 0.2% glucose were tested. Complementation was observed only at 0.2% arabinose for ftsL and ftsQ, but over a wide range of arabinose concentrations for ftsI.
Molecular biological procedures and oligonucleotides. Standard techniques were employed for cloning and analysis of DNA, PCR, electroporation, and transformation (36) . Enzymes used to manipulate DNA were from New England BioLabs. DNA sequencing was performed for double-stranded plasmid templates either manually (Sequenase; U.S. Biochemicals) or with an automated sequencer (ABI).
The oligonucleotides (5Ј33Ј) used to make the different constructions were as follows: 1, pBAD18-5Ј (CTGTTTCTCCATACCCGTT); 2, pBAD18-3Јalt (GG CTGAAAATCTTCTCT Construction of wild-type genes under P BAD control. Plasmids that express swap proteins starting from pLMG130 (malF), pLMG161 (ftsQ), pLMG173 (ftsI), and pLMG180 (ftsL) were constructed. These are derivatives of pBAD18 and express the genes indicated under the control of the araBAD promoter (19) . pLMG130 was constructed by subcloning a 2.2-kbp EcoRI-HindIII fragment containing the wild-type malF gene and part of the malG gene from plasmid pDHB32 (6) into the same sites of pBAD18. To construct pLMG161, a 931-bp EcoRI-KpnI (partial digest) fragment from plasmid pMJC103 (7) was cloned into the same sites of pBAD18. The EcoRI site is 13 bp upstream of the ribosome binding site (RBS) for ftsQ, and the second KpnI site, at the end of the fragment, is 42 bp downstream of the stop codon. Construction of pLMG173 was done in two steps. First, a HpaI-NruI (partial digest) fragment encoding the ftsI gene from pZ26::TnphoAL112 (7) was subcloned into the SmaI site of pBAD18. Both orientations of the insert were obtained, and a plasmid with an insert orientation that placed ftsI under P BAD control was chosen. Second, by using oligonucleotide 21 and site-directed mutagenesis, an EcoRI site was introduced 9 bp upstream from the proposed RBS of ftsI. Then, the sequences upstream of this RBS were deleted by dropping out the DNA between the EcoRI site of the vector and the new EcoRI site. This placed ftsI immediately downstream of the P BAD promoter and eliminated all non-ftsI sequences. Plasmid pLMG180, which contains a 412-bp fragment encoding ftsL under P BAD control, has been described elsewhere (18) . All four genes cloned into pBAD18 were contained between the EcoRI and HindIII sites of the vector and retained their native RBSs.
Construction of swaps. Versions of the pLMG plasmids described above, in which each gene contained a restriction site for EagI and MscI flanking the MSS, were constructed according to the following steps (here described for ftsL) (see Fig. 2 ).
(i) Introduction of an MscI site at the 5 end of the MSS. The cytoplasmic domain and MSS were amplified by PCR with primers 1 (5Ј pBAD primer) and 15 with pLMG180 as the template. The 5Ј pBAD primer aligns to vector sequences beyond the RBS of the gene and the EcoRI site of the vector. Primer 15 contains an MscI site at its 5Ј end and introduces this site near the 3Ј end of the PCR product. The amplified DNA fragment was made blunt end with T4 DNA polymerase, digested with EcoRI, and then ligated into pBAD18 that had been digested with EcoRI and SmaI. The resulting plasmid was called pLD1.
(ii) Introduction of an EagI site at the 3 end of the MSS. The cytoplasmic domain was amplified by PCR with primers 1 (5Ј pBAD primer) and 13 with pLMG180 as the template. Primer 13 introduced an EagI site near the 3Ј end of the PCR fragment. The amplified fragment was made blunt-end with T4 DNA polymerase, cut with EcoRI, and ligated into pBAD18 that had been digested with EcoRI and SmaI. The resulting plasmid was called pLD11.
(iii) Introduction of both the EagI and the MscI sites into the same fragment of ftsL. The MSS was PCR amplified with primer 14, which introduced an EagI site at the 5Ј end of the MSS, and primer 2 (3Ј pBAD primer) with pLD1 as the template. The fragment obtained was digested with EagI and SphI and ligated into pLD11 that had been digested with the same enzymes. The resulting plasmid was named pLD16.
(iv) Construction of a complete ftsL gene containing both the EagI and the MscI restriction sites. The periplasmic domain of ftsL was amplified by PCR with primers 16 and 2 with pLMG180 as the template. Primer 16 introduced an MscI site at the 5Ј end of the fragment encoding the periplasmic domain. The fragment obtained was digested with MscI and HindIII and ligated into pLD16 that had been cut with the same enzymes. The resulting plasmid was called pLD45, and its gene is referred to as L EagI /L MscI /L (i.e., L cyt /L mss /L perip ) to indicate the presence of the restriction sites at the ends of the corresponding domains. L EagI / L MscI /L was functional, as judged by complementation, as were I EagI /I MscI /I, Q EagI /Q MscI /Q, and F EagI /F MscI /F.
(v) Construction of genes with swapped domains. Chimeric ftsL genes were constructed by exchanging the fragments that correspond to the cytoplasmic and MSS domains. For instance, to construct MSS swaps for FtsL, the EagI-MscI fragment of pLD45, which encodes the FtsL MSS, was substituted by EagI-MscI fragments derived from malF, ftsI, and ftsQ to produce Cloning ftsI swaps into pBAD18-Kan. Because ␤-lactamase destroys the substrate fluorescein hexanoic 6-aminopenicillanic acid (FLU-C 6 -APA) used to test penicillin-binding activity, wild-type ftsI and three swap alleles were subcloned into a vector that confers Kan r rather than Amp r . This was accomplished by digesting pLMG173 (ftsI), pLD43 (F EagI /F MscI /I), pLD59 (L EagI /I MscI /I), and pLD120 (I EagI /Q MscI /I) with EcoRI and BsaI, gel isolating the 2-kbp DNA fragment carrying the ftsI allele, and ligating this fragment into pBAD18-Kan (19) that had been cut with the same enzymes. The resulting plasmids were named pLD139 to 142.
Cloning of MBP-fusion proteins. (i) MBP-FtsI (periplasmic domain)
. Plasmid pMAL-c2, which allows for fusion of proteins to the carboxyl terminus of a signal sequenceless maltose-binding protein (MBP) derivative, was digested with EcoRI, made blunt ended by treatment with Klenow fragment in the presence of deoxynucleoside triphosphates, and cut with HindIII. This vector fragment was then ligated to the 1.7-kbp MscI-HindIII fragment from pLD30 carrying the periplasmic domain of FtsI. The resulting plasmid was converted from Amp r to Kan r by digestion with DraI, which cuts twice within the bla gene, and ligating in a 1.3-kbp fragment (BamHI, then made blunt ended with Klenow fragment) conferring Kan r from plasmid pUC4K (from Pharmacia Biotech). The resulting plasmid was named pDSW156.
(ii) MBP-FtsL (periplasmic domain). DNA encoding the periplasmic domain of ftsL was amplified from pLMG180 by PCR with primers 22 and 2. After treatment with T4 DNA polymerase and HindIII, the resulting 210-bp fragment was ligated into pMAL-c2 that had been digested with XmnI and HindIII. Ampicillin-resistant clones were screened for expression of an MBP-FtsL fusion protein by Western blotting with antibody against FtsL. The resulting plasmid, pLMG322, produced a fusion with no polylinker-encoded amino acids between MBP and FtsL.
Antibodies. Antibodies against synthetic peptides derived from the sequence of FtsI (FtsI-1, MKAAAKTQKPKRQEEHC; FtsI-2, CEPDALTTGDKNEFV) or FtsL (FtsL-1, CREQLVLERDALDIE; FtsL-2, CMQHVDPSQENIVVQK) were raised in rabbits by ImmunoDynamics. FtsI-1 corresponds to the first 16 residues of the cytoplasmic domain, and FtsI-2 corresponds to the last 14 residues of the mature (28) periplasmic domain. FtsL-1 and FtsL-2 are derived from periplasmic domain; FtsL-1's sequence is close to the MSS, and FtsL-2 corresponds to the carboxyl terminus of FtsL. A strong reaction of the antibodies against FtsI was observed after 4 months of boostings, while for FtsL, 8 months were necessary. The antibody against FtsI was affinity purified (34) against the isolated periplasmic domain of FtsI. Antibody against FtsL was similarly purified against an MBP-FtsL (periplasmic domain) fusion protein expressed by pLMG322.
Western blotting. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose (36) .
Immunodetection was performed with antipeptide antibodies against FtsI or FtsL and the ECL Western blotting system (Amersham). For quantitation, film was scanned with a computing densitometer (Molecular Dynamics).
To determine the steady-state levels of expression of FtsI swap proteins, derivatives of KS272 or LMG64 carrying appropriate plasmids were grown at 30°C in NZY-ampicillin to an optical density at 600 nm (OD 600 ) of ϳ0.5. Cultures were then diluted fivefold into 42°C NZY-ampicillin containing arabinose to induce expression of the plasmid-borne swap allele, if any. After 1 h, the OD 600 had returned to about 0.5, and microscopic examination of LMG64 derivatives revealed extensive filamentation (except in the cases of pLMG173 and pLD30). One milliliter of cells was pelleted by centrifugation and resuspended in 100 l of SDS-sample buffer per OD 600 unit of 0.5. Samples were boiled for 5 min, and 10 l was loaded onto a 10% polyacrylamide-SDS gel.
The steady-state levels of FtsL swap proteins were determined similarly, except that cultures were always grown at 37°C, and the swap constructs were detected in ftsL ϩ cells only (KS272 and LMG194). Cells containing swaps or control plasmids (pLMG180, pLD45, and pBAD18) and cells containing the chromosomal insertion mutation complemented by pLMG180 were grown to mid-log phase in NZY-ampicillin (plus 0.2% arabinose in the case of the null mutant). Cells were harvested, resuspended in fresh medium with 0.2% arabinose, and diluted 10-fold into NZY-0.2% arabinose; a fraction of the culture of the null mutant was resuspended and grown in NZY-0.2% glucose. After 2.5 h, the null mutant had formed filaments in the presence of 0.2% glucose but showed normal cells and efficient complementation in the presence of arabinose. At this time, 1 ml of cells was pelleted by centrifugation and resuspended in 100 l of SDS-sample buffer per OD 600 of 0.5. Samples were boiled for 5 min, and 10 l was loaded onto a 15% polyacrylamide-SDS gel.
Detection of FtsI with FLU-C 6 -APA. FLU-C 6 -APA was synthesized as described elsewhere (33) , and its concentration in 50 mM sodium phosphate buffer (pH 7.0) was determined by using E 494 ϭ 68 mM Ϫ1 as the extinction coefficient. The strains were grown overnight in NZY-kanamycin, inoculated 1:500 into fresh medium, and grown at 37°C to an OD 600 of ϳ0.5. Expression of the plasmid-borne FtsI protein (if any) was then induced by adding arabinose to a final concentration of 0.002%, except for MBP-FtsI expressed from pDSW156, which was induced with 50 M isopropyl-␤-D-thiogalactopyranoside. One hour after induction, the cells were harvested by centrifugation and resuspended in spheroplasting buffer (50 mM Tris-HCl [pH 8.0], 5 mM Na 2 EDTA, 500 mM sucrose). One milliliter of culture at an OD 600 of 1.0 was resuspended in 50 l; for cultures at other ODs, the volume of buffer was adjusted accordingly.
Spheroplasting buffer rendered the outer membrane permeant to FLU-C 6 -APA. For routine assays, FLU-C 6 -APA was added to a final concentration of 20 M, and assay mixtures were incubated at 30°C for 30 min. Samples were withdrawn at various times, added to an equal volume of 2ϫ Laemmli gelloading buffer to quench the reaction, and boiled for 5 min. A 10-l volume was loaded onto a 10% polyacrylamide-SDS gel, and proteins were separated by electrophoresis. Proteins labelled with FLU-C 6 -APA were visualized and quantitated with a Molecular Dynamics FluorImager 575. A second gel was run to determine the level of FtsI by Western blotting. Samples for Western blotting were generally diluted by 10-to 100-fold.
For the experiment shown in Fig. 5 , procedures were modified to allow lysis of the cells. Cells resuspended in spheroplasting buffer were converted to spheroplasts by incubation on ice in the presence of 0.2-mg/ml lysozyme for 20 min. FLU-C 6 -APA was then added to a final concentration of 20 M, and spheroplasts were incubated at 30°C for 20 min, at which time a sample was taken and added to 2ϫ Laemmli gel-loading buffer to assess binding of FLU-C 6 -APA to FtsI derivatives in intact spheroplasts. The remaining spheroplasts were then pelleted in a Microfuge, the buffer containing FLU-C 6 -APA was discarded, and the spheroplasts were lysed by resuspension in 50 mM Tris-HCl (pH 8.0)-5 mM MgCl 2 . After incubation for 5 min at 30°C in the presence of 1-g/ml DNase I to reduce viscosity, an equal volume of 2ϫ spheroplasting buffer was added, followed by FLU-C 6 -APA to a final concentration of 20 M. Samples were taken after 10 and 20 min of incubation at 30°C to assess binding of FLU-C 6 -APA to FtsI derivatives in lysed spheroplasts.
RESULTS
Assembling swap constructs. In planning to study Fts swap constructs, we considered it highly desirable to be able to control the levels of expression of the hybrid proteins in our analysis of their functionality. On the one hand, it seemed important to be able to examine the abilities of such constructs to complement fts mutants when they are expressed at lower levels that are at least somewhat comparable to wild-type levels. On the other hand, some constructs might exhibit only partial but significant functionality that would be observed only at high expression levels. Furthermore, since membrane proteins are often deleterious to the cell at high levels of expression, tight control of their expression could also be crucial for this analysis. Finally, dominant-negative effects of the swaps might be observed only at higher levels of expression. Therefore, all swap constructs were made starting with the malF and fts genes cloned into a plasmid containing the tightly regulated promoter for the arabinose operon. The plasmid that we used was pBAD18 as described by Guzman et al. (19) .
We wished to obtain constructs in which one or two domains of each membrane protein were swapped with another. For each of the fts genes cloned into pBAD18, we introduced restriction sites at positions in the gene's DNA sequence corresponding to the amino-terminal and carboxy-terminal borders of the presumed transmembrane segment using PCR (Fig.  2) . (It should be remembered at this point that, except for the very few membrane proteins for which three-dimensional structures exist, the definition of the exact borders of transmembrane segments is based only on sequence examination and the rules that have evolved for predicting these borders.) For malF (6, 14) , a protein with eight MSSs, we introduced these restriction sites at the borders of the first MSSs. This MSS can be deleted without affecting the transport activity of MalF (12) . In planning these constructs, we also attempted to ensure that the charge distribution at each end of the MSS segment corresponded to that necessary to maintain the original topology of these proteins. That is, basic amino acids at the amino terminus of the MSS and acidic residues (or a net neutral charge) at its carboxy terminus are determinants of the appropriate orientation (5, 25, 39, 41) . Relevant amino acid sequence changes encoded by the introduction of restriction sites into these genes are shown in Fig. 3 . After construction of the various swaps, we verified their structures by restriction mapping and by DNA sequencing of all gene segments made by PCR. We use a simple nomenclature to describe each swap construct. Each swap is designated by three letters, such that the first letter identifies the protein whose coding region corresponds to the amino terminus (the cytoplasmic domain) of the protein, the second corresponds to the protein from which the MSS was derived, and the third represents the protein from which the periplasmic domain was derived. Thus, QLL has the cytoplasmic domain of FtsQ and the MSS and periplasmic domains of FtsL.
Expression and topology of swap constructs. We tested our FtsI and FtsL constructs to ensure that each of them expressed its swap protein. For proteins containing the periplasmic domains of FtsI, we found that all constructs expressed substantial levels of the proteins as assayed by Western blots (Fig. 4) . The amounts of protein varied according to the constructs. This variation was probably due to the differing efficiencies of the translation start signals for the particular protein from which the amino terminus of a swap derived. We note here that swap constructs in which the FtsQ amino-terminal domain preceded sequences from one of the other Fts proteins consistently expressed levels of hybrid protein lower than those seen with other swaps. These findings suggest that the FtsQ translation start signal, at least in these constructs, is weaker than those of FtsI and FtsL (Fig. 4) . Previously presented results indicated that FtsQ has a weak translation start signal (26) .
For FtsL, most of the constructs expressed protein detectable in Western blots with anti-FtsL antibody. However, we have never observed any product from QQL, QLL, or wildtype L in blots. For IIL and LLL, cross-reacting protein was seen in one of several blots that we performed. The anti-L antibody does not appear to be very effective, since it is also unable to reveal chromosomally expressed FtsL in blots. The failure to detect the constructs with a Q amino terminus is perhaps not surprising, since, as mentioned above, such constructs are expressed at lower levels in general. The failure to detect wild-type FtsL expressed from the plasmid is more surprising. However, since this plasmid effectively complements an ftsL null mutation and fusions of phoA (encoding alkaline phosphatase) to ftsL in this plasmid give high levels of alkaline phosphatase activity (see below), FtsL is obviously expressed. The alkaline phosphatase activity levels of fusions to wild-type FtsL and to the FtsL engineered with restriction sites in the gene are similar to those of fusions derived from swaps for which we can readily detect protein (data not shown). The inability to detect wild-type FtsL in these experiments raises the possibility that wild-type FtsL is unstable while the swap constructs are stable.
Although we do not have antibody to FtsQ, since all of our FtsQ swap constructs complemented an ftsQts mutant, they must be expressed (Table 2 and below). We specifically designed the swap constructs so as to make it likely that the topology of each protein would be such that the periplasmic domain of the original protein was maintained in the periplasm. Nevertheless, we tested a number of the FtsI swaps to verify this outcome. The reason for focusing on FtsI is that In the case of FtsI, vector alone was examined in both the Ts mutant LMG64 (far left) and wild-type strain KS272 (far right) to allow the steady-state levels of chromosomally expressed Ts and wild-type (Wt) FtsI proteins to be compared with the levels of expression of swap proteins. All FtsI swaps were induced with 0.002% arabinose, except for QQI and QII, which were weakly expressed and were induced with 0.2% arabinose. All FtsL swaps and the FtsL81-PhoA fusion protein were induced with 0.2% arabinose. The lane marked LIL ϩ ILI was included because this combination of the two swaps was tested to see whether they would complement an FtsL depletion strain when expressed in the same cell. They did not.
this verification was facilitated by the penicillin-binding properties of the periplasmic domain of the protein (38) . We were able to use a fluorescent penicillin derivative (FLU-C 6 -APA) (23, 33) that is membrane impermeant to show that the penicillin-binding domain of FtsI lies outside the cytoplasmic membrane rather than inside the cytoplasm. Specifically, we compared wild-type FtsI with a cytoplasmically localized version of FtsI in which the MBP (lacking its signal sequence) was fused to the periplasmic domain of FtsI. Spheroplasts derived from cells expressing FtsI or MBP-FtsI were incubated with FLU-C 6 -APA for 20 min, at which time the spheroplasts were lysed and incubation continued for an additional 20 min. Samples 
a Complementation of Ts mutants was determined by efficiency of colony formation and colony size at the nonpermissive temperature (42°C) in Ts strains harboring the different swap plasmids. Complementation by transduction was done with P1, crossing ftsL, ftsI or ftsQ null mutations onto the chromosome of wild-type strains harboring the different swap plasmids. ss, signal sequence; perip, periplasmic domain; ND, not determined; NA, not applicable.
b By Western blotting (see Fig. 4 ). Some data not shown. LL, low levels. c For FtsI periplasmic domain constructs, correct topology (i.e., periplasmic domain in the periplasm) was determined by binding of FLU-C 6 -APA to swap proteins in permeabilized cells (see Fig. 5 and 6 ). For FtsL periplasmic domain constructs, the periplasmic domain of the L81 ftsL-phoA fusion containing 23 residues of the FtsL periplasmic domain fused to mature alkaline phosphatase (AP) was used to replace the FtsL periplasmic domain in the swap plasmids. Alkaline phosphatase activity levels for the FtsL-swap-AP fusions were determined as described elsewhere (18) and were correlated with the amounts of protein observed in Western blots (Fig. 4 and data not shown) .
d Early-log-phase cultures of Ts strains were grown at the permissive temperature in rich medium and were shifted to the nonpermissive temperature under inducing conditions.
e Production and periplasmic localization of this protein have been previously reported (4) .
were removed at various time points and analyzed for fluorescein-labelled protein by SDS-PAGE and amounts of FtsI or MBP-FtsI by Western blotting (Fig. 5) . FtsI bound FLU-C 6 -APA in spheroplasts, and labelling did not increase noticeably after lysis of spheroplasts. In contrast, the cytoplasmically localized MBP-FtsI hybrid protein was labelled only after spheroplasts were lysed. To ask whether the swap proteins had the correct membrane topology and retained transpeptidase activity, three plasmidborne swap proteins (FFI, LII, and IQI) were compared to plasmid-borne wild-type FtsI and chromosomally encoded wild-type FtsI in a penicillin-binding assay. Cells were incubated for 30 min in the presence of FLU-C 6 -APA and then samples were removed to determine the extent of labelling and the amount of each FtsI protein (by Western blotting [Fig. 6]) . In each case, the amount of FLU-C 6 -APA bound was directly proportional to the amount of FtsI protein. In a separate experiment, we found that the kinetics of labelling were similar for FFI and wild-type FtsI (Fig. 6) . Taken together, our results suggest that substitution of the amino-terminal cytoplasmic domain and/or transmembrane segment of FtsI does not have major effects on the periplasmic localization or on the conformation of the periplasmic domain. The latter observation is consistent with previous evidence that a soluble form of FtsI created by deleting the cytoplasmic domain and MSS has normal penicillin-binding properties (13, 16) .
Again, since all of the FtsQ constructs complemented an ftsQts mutation, they must express enough protein with the proper topology to allow such complementation. Since we had available no specific test for FtsL topology, we generated fusions of FtsL, FtsL engineered with restriction sites, and the FtsL swaps to alkaline phosphatase using a fusion previously shown to be a good indicator of proper topology for FtsL (ftsL-phoAL81) (18) . In these hybrid proteins, alkaline phosphatase is fused to residue 24 of the FtsL periplasmic domain. All swaps, except for LFL and QLL, were tested and gave high levels of alkaline phosphatase expression, as observed on indicator plates containing 5-bromo-3-chloro-indolyl-phosphate. We believe that given (i) the results with alkaline phosphatase fusions and (ii) the care with which we generated our constructs so as to ensure proper topology, these constructs are also highly likely to assume the correct arrangement in the membrane. The considerable experience in predicting topology of constructs in numerous other studies reinforces this conviction (25, 29, 40) .
Complementation by swap constructs: swaps containing the FtsI periplasmic domain. We first tested complementation of an ftsI(Ts) mutation by plasmids encoding swap constructs in which either the amino-terminal cytoplasmic domain or the transmembrane segment of FtsI or both were replaced by the analogous domains from the other membrane proteins. We tested complementation for growth at 42°C on both rich and minimal media and at different levels of expression of the swap constructs by varying the arabinose concentration in the media. Growth was assessed by streaking out on solid medium. On rich medium, we found essentially no complementation by swap constructs. (High-level expression of the QII hybrid reproducibly showed some growth in the heavy part of the streak, but no isolated colonies grew up, even upon restreaking.) However, in minimal medium, with various results, we did see growth of certain strains. In one case, this occurred even at the very low levels of expression of the swap that resulted from the absence of arabinose and the presence of glucose. There was also some curious variation in the relative abilities of wild-type ftsI and the ftsI construct with the engineered restriction sites to complement. This may be due to differences in the levels of the two proteins.
Thus, while under many conditions the ftsI swap constructs did not appear to be functional, these studies utilizing the ftsI(Ts) mutation yielded ambiguous results. It seemed possible that interactions between the altered FtsI of the Ts mutant and the hybrid FtsI molecules might either rescue the function of the FtsI(Ts) mutant protein or generate dimers that were functional. Therefore, we decided to utilize an ftsI null mutant for further studies. The null mutation chosen is one in which the transposon TnphoA is inserted in the ftsI gene in such a way that alkaline phosphatase is fused to a codon (Asp122) in the periplasmic domain of FtsI (7a). This strain is unable to grow unless a complementing plasmid carrying the ftsI gene is present. When the complementing ftsI gene is under the control of the arabinose promoter, shutting off this promoter results in a severe cell division defect, and cells produce filaments that eventually lyse.
We determined whether swap constructs would complement the ftsI null mutation as follows. Plasmids encoding wild-type ftsI and each of the swaps were transformed into strain LMG194, which carries a wild-type ftsI gene and a Tn10 insertion in leu, which is 75% linked to ftsI by P1 transduction. A P1 transducing lysate made on a Leu ϩ strain carrying the ftsI null mutation was then used to transduce the strains harboring these plasmids. Since the transposon TnphoA includes a kanamycin resistance gene, we could monitor transfer of the null mutation into the recipient strains by selecting for kanamycin resistance and leucine prototrophy. We found that the strains carrying the ftsI wild-type gene and the ftsI gene with engineered restriction sites could be transduced to kanamycin resistance on minimal medium, while none of the swap construct strains yielded transductants. Thus, it appears that none of the swap constructs are able to complement an ftsI null mutation.
FtsQ. As with ftsI, we first studied complementation by FtsQ swaps using an ftsQ(Ts) mutation. In contrast to the initial ftsI studies, we found complementation of the Ts mutant by many of the constructs on both rich and minimal media ( Table 2 ). Every swap construct was able to complement on minimal medium. In some cases, the complementation was most effective at high arabinose concentrations (high levels of swap expression), and in others it was most effective at lower levels of expression. We have already pointed out here that expression from the ftsQ translation initiation sites may be considerably lower than that from those of ftsI, ftsL, and malF. Thus, the FtsQ swaps expressed from an FtsQ amino terminus are able to complement at 0.2% arabinose, while all other swaps appear to be toxic at these levels. In general, the results suggest that constructs that contain both the transmembrane segment and the periplasmic domain of FtsQ complement better than those with only the periplasmic domain.
Given the contrasting findings in complementation studies with the ftsI(Ts) mutant and the ftsI null mutant, we proceeded to test swap constructs expressing the FtsQ periplasmic domain in a null (ftsQ-phoA fusion) ftsQ mutant. Here also, there was a difference between the two types of complementation experiments. First, we found that any swap construct in which the cytoplasmic domain of FtsQ was replaced could not complement the ftsQ null mutant. In contrast, constructs in which the cytoplasmic domain was intact but the FtsQ MSS was replaced were still functional. Even the construct in which the MalF MSS replaced the FtsQ MSS complemented the null mutation. Thus, the specific sequence of the MSS of FtsQ is not required for its function and may act only as a membrane-anchoring sequence.
FtsL. For FtsL, we had no Ts mutants but only an ftsL-phoA null mutation. In this case, alkaline phosphatase is fused to codon 24 of the FtsL periplasmic domain. A bacteriophage P1 lysate made on the null mutant was used to transduce strains carrying plasmids encoding the various ftsL constructs plus a chromosomal wild-type ftsL gene to kanamycin resistance and leucine prototrophy. While the strains carrying the wild-type ftsL or the ftsL engineered with restriction sites could be transduced to kanamycin resistance, none of the swap constructexpressing strains could.
Possible dominant effects of swap construct expression. In some cases, we observed growth-inhibitory effects at the highest level of expression of swap constructs in ftsI(Ts) and ftsQ(Ts) backgrounds (not shown). Examination of cells under these conditions showed a variable degree of filamentation. However, there was no particular pattern to these effects. It is known that, in general, overexpression of membrane proteins frequently leads to growth inhibition. Thus, the significance of these observations is not clear.
DISCUSSION
The studies of exchanges of domains between membrane proteins involved in cell division that we report here provide an approach to defining the roles of various domains of these proteins. They point to domains that are likely to be essential for the function of the proteins and suggest experiments to further explore the function of these proteins and any partners with which they may interact.
FtsI. Previous studies had suggested that at least a membrane anchor was necessary for FtsI to be functional for cell division (16, 17a) . Conversion of this protein to a periplasmic location by replacement of the cytoplasmic domain and MSS by a cleavable signal sequence resulted in the inability to complement an ftsI mutation. Dai et al. (10) reported that replacement of the cytoplasmic and transmembrane domains of FtsI with comparable sequences from the unrelated protein MalG resulted in a noncomplementing construct, although topology and expression were not reported. Our results also suggest that both the cytoplasmic domain and the MSS are essential functional components of FtsI. The MSS appears sensitive to very slight alterations. The addition of a single amino acid or the change of an amino acid in or adjacent to the MSS reduces FtsI function. For example, introducing a StuI restriction site at the 3Ј end of the MSS inserts a leucine into the MSS and results in an I/I StuI /I protein that cannot support cell division (Table 2) . More recent studies on a variety of alterations of the MSS further support the conclusion that the sequence, length, and arrangement of this sequence is critical for FtsI function (43) . The essentiality of the cytoplasmic domain indicates that it is not simply a sequence that contributes to the anchoring of the protein in the proper orientation in the membrane. Rather, these results suggest that the cytoplasmic domain performs an important role, perhaps interacting with some other component of the cell division apparatus.
FtsL. In terms of complementation, the results with FtsI and FtsL are the same. They suggest that the FtsL cytoplasmic and MSS domains are important for the functioning of the protein.
Mutants of the periplasmic domain of FtsL also interfere with the cell division process (18) .
FtsQ. All constructs that retain the periplasmic domain of FtsQ complement to some degree an ftsQ(Ts) mutant. Again, Dai et al. (10) describe a MalG-FtsQ construct analogous to their MalG-FtsI hybrid referred to above. This construct also complemented the ftsQ(Ts) mutation; the expression and topology of this construct were not reported.
However, our studies of complementation of an ftsQ null mutant suggest that studies with the ftsQ(Ts) mutation are misleading. Specifically, the results with complementation of the null mutant by swaps of the cytoplasmic domain of FtsQ, as with FtsI and FtsL, show that this domain is essential to the function or localization of FtsQ. In contrast, the null mutant could be complemented by constructs in which only the MSS of FtsQ was replaced. The fact that the substitution of the MalF MSS allows functionality of FtsQ suggests that there are no signals in the MSS that are important for subcellular localization. That is, if, for example, the MSS of FtsQ directed it to the cell septum where it had to be localized in order to be functional in cell division, replacement of this domain with the analogous sequence of MalF, which we presume is not localized to the septum, should have eliminated this function. This conclusion must be qualified, since overexpression of the constructs may produce enough of the hybrid proteins so that a sufficient amount is localized to the cell septal region simply by random distribution. However, we did analyze complementation at low levels of induction of these constructs and still obtained positive results. Our results suggest that although the specific sequence of the FtsQ MSS is not important, an MSS is likely required for FtsQ function in cell division, since both the FtsQ periplasmic and cytoplasmic domains appear to be essential.
Cautions in swap analysis. In the analysis of swap proteins, it is obviously essential to verify that the proteins are expressed and are at least stable enough so that substantial levels of the protein are present at steady state. We have demonstrated that this is the case for all of the constructs containing the FtsI periplasmic domain by Western blotting with FtsI antibodies. Similarly, we could show the presence of greater-than-wildtype levels of many of the constructs containing the FtsL periplasmic domain using FtsL antibody. In the case of FtsQ, since all of the constructs complemented in the ftsQ(Ts) background, they must all be expressed.
Although the swaps were constructed so as to make it most likely that their membrane topology would be the same as that of the wild-type protein, we checked with certain swaps to determine if that was the case. With swaps containing the FtsI periplasmic domain, this was done by assaying binding of a fluorescent penicillin analog and showing that the binding was external to the cytoplasmic membrane. These findings also showed that the transpeptidase activities of these hybrid proteins were probably intact. Again, with FtsQ, the positive complementation results with the ftsQ(Ts) mutant made it unnecessary to do topology analysis, since these findings indicate that at least a significant fraction of the protein has the proper topology required for functionality. With FtsL, the results obtained from phoA fusions to FtsL and its swap derivatives strongly suggest that the hybrid proteins assumed the proper topology. Also, we have argued above that it is highly likely that FtsL constructs assumed the proper topology, given the results with FtsQ and FtsI and the way in which the constructs were designed.
We interpreted absence of complementation to mean that the segment(s) replaced in a particular construct is essential for the function of the protein. However, it is possible that in the process of replacing, for instance, a cytoplasmic domain of a protein, we subtly altered the position, structure, or orientation of the MSS. Then, it is not the cytoplasmic domain that is essential but the MSS and its particular arrangement in the membrane. This type of alternative interpretation is potentially subject to testing, since one might expect that it would be relatively easy to restore function to the hybrids by simple mutational changes. If such mutations could be found, they would show that certain of the negative complementation results would have to be reinterpreted and that the specific sequences of certain domains are not essential. Such results would also be of significant interest in terms of the organization of membrane proteins in general.
Contrasting complementation results with an fts(Ts) mutation and an fts null mutation. The failure of swap constructs with the FtsI periplasmic domain to complement a null ftsI mutation indicates that these proteins are not functional on their own. Yet some of them are able, under some conditions, to complement an ftsI(Ts) mutation. We can conceive of several possible explanations for this difference. First, if FtsI is normally dimeric, then the FtsI(Ts) protein may be able to form a dimer with certain of the swap proteins generating a partially functional heterodimer. Alternatively, overexpression of swap proteins may rescue the function of the FtsI(Ts) protein by, for example, saturating cellular proteases that might otherwise degrade the Ts protein. Since overexpression of these membrane proteins can have some deleterious effects on the cell, it is clear that they can interfere with some cellular processes.
Similar explanations may account for the differences in complementation between the ftsQ(Ts) mutant and the ftsQ null mutant.
Further work. Our results suggest that for FtsI and FtsL, the cytoplasmic, membrane, and periplasmic domains of the proteins are essential for their function. Thus, all domains of the protein may be usefully studied by mutagenic analysis. In the introduction, we suggested various possible roles for these domains. One possible role for a domain is to signal localization to the cell septum via interaction with one of the other Fts proteins or with other unidentified cellular components. By immunofluorescence microscopy, it is now possible to observe the positioning of membrane proteins such as FtsI to the cell septum (42) . Thus, the effects of substituting one or another domain of this protein on its localization to the septum can be used to define the localization signals and to do mutagenic analysis of such signals.
One may also usefully pursue analysis of protein-protein interactions of different domains of these proteins. For example, the yeast two-hybrid system or an analogous bacterial system could reveal components that interact with the hydrophilic domains of FtsI and FtsL. The yeast system may not be useful for seeking interactions between MSSs, since these domains might cause problems for localization in the yeast cell and prevent the localization of hybrid protein to the cell nucleus where effects are assayed.
